Tradename | Company | Number | Date | Products |
---|---|---|---|---|
VI-TWEL | Bayer | N-007012 DISCN | 1982-01-01 | 1 products |
RUBIVITE | Bel-Mar Laboratories | N-010791 DISCN | 1982-01-01 | 5 products |
RUBRAMIN PC | Bristol Myers Squibb | N-006799 DISCN | 1982-01-01 | 3 products, RLD |
CALOMIST | Endo | N-022102 DISCN | 2007-07-27 | 1 products |
NASCOBAL | Endo | N-019722 DISCN | 1996-11-05 | 1 products |
NASCOBAL | Endo | N-021642 DISCN | 2005-01-31 | 1 products, RLD |
REDISOL | Merck & Co | N-006668 DISCN | 1982-01-01 | 1 products |
BERUBIGEN | Pharmacia & Upjohn | N-006798 DISCN | 1982-01-01 | 1 products |
CYANOCOBALAMIN | Warner Chilcott | N-007085 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DICOPAC KIT | GE Healthcare | N-017406 DISCN | 1982-01-01 | 1 products |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
DEPINAR | Armour Pharmaceutical | N-011208 DISCN | 1982-01-01 | 1 products |
Brand Name | Status | Last Update |
---|---|---|
adult infuvite multiple vitamins | New Drug Application | 2025-08-18 |
allevia | unapproved drug other | 2025-02-27 |
animi-3 | unapproved drug other | 2013-02-06 |
animi-3 with vitamin d | unapproved drug other | 2011-05-23 |
bacmin | unapproved drug other | 2014-05-02 |
bal-care dha | unapproved drug other | 2012-05-01 |
bal-care dha essential | unapproved drug other | 2012-05-01 |
bp vit 3 | unapproved drug other | 2025-02-13 |
c-nate dha | unapproved drug other | 2024-01-22 |
centratex | unapproved drug other | 2024-01-31 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Vitamin b 12 deficiency | D014806 | EFO_0000734 | E53.8 | 2 | 4 | 2 | 5 | 49 | 60 |
Anemia | D000740 | EFO_0004272 | D64.9 | — | 4 | 9 | 5 | 37 | 53 |
Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | 2 | 4 | 3 | 17 | 25 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 2 | 2 | 3 | 11 | 18 |
Iron deficiencies | D000090463 | — | E61.1 | — | 1 | 2 | 2 | 14 | 18 |
Hyperhomocysteinemia | D020138 | — | — | — | 1 | 2 | 1 | 13 | 17 |
Cognitive dysfunction | D060825 | — | G31.84 | 1 | 4 | — | 1 | 11 | 17 |
Diabetic neuropathies | D003929 | EFO_1000783 | — | 1 | 3 | 2 | 1 | 10 | 16 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 3 | 1 | 1 | 12 | 16 |
Iron-deficiency anemia | D018798 | — | D50 | — | — | 1 | 3 | 12 | 16 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 1 | 14 | 9 | — | 3 | 25 |
Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | 2 | 4 | — | 13 | 17 |
Covid-19 | D000086382 | — | U07.1 | 2 | 2 | 3 | — | 9 | 15 |
Depression | D003863 | — | F33.9 | — | 3 | 1 | — | 8 | 11 |
Pregnancy | D011247 | EFO_0002950 | Z33.1 | 1 | — | 2 | — | 8 | 11 |
Lung neoplasms | D008175 | — | C34.90 | 1 | 9 | 2 | — | — | 10 |
Parkinson disease | D010300 | EFO_0002508 | G20 | — | 1 | 1 | — | 9 | 10 |
Syndrome | D013577 | — | — | — | 2 | 3 | — | 6 | 9 |
Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 2 | 2 | — | 7 | 9 |
Alzheimer disease | D000544 | EFO_0000249 | F03 | — | 1 | 1 | — | 6 | 8 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | 3 | — | — | 11 | 15 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 2 | 3 | — | — | 6 | 11 |
Recurrence | D012008 | — | — | 5 | 5 | — | — | — | 8 |
Brain injuries | D001930 | — | S06.9 | 2 | 1 | — | — | 4 | 6 |
Aging | D000375 | GO_0007568 | R41.81 | — | 1 | — | — | 4 | 5 |
Fibromyalgia | D005356 | EFO_0005687 | M79.1 | 2 | 1 | — | — | 3 | 5 |
Hepatitis | D006505 | — | K75.9 | — | 3 | — | — | 1 | 4 |
Hepatitis a | D006506 | EFO_0007305 | B15 | — | 3 | — | — | 1 | 4 |
Autism spectrum disorder | D000067877 | — | F84.0 | — | 1 | — | — | 3 | 4 |
Ulcerative colitis | D003093 | EFO_0000729 | K51 | 1 | 2 | — | — | 1 | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Inflammation | D007249 | MP_0001845 | — | 2 | — | — | — | 11 | 13 |
Hypertension | D006973 | EFO_0000537 | I10 | 1 | — | — | — | 4 | 5 |
Child development | D002657 | — | — | 1 | — | — | — | 3 | 4 |
Heart failure | D006333 | EFO_0003144 | I50 | 1 | — | — | — | 3 | 4 |
Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 1 | 2 |
Sezary syndrome | D012751 | — | C84.1 | 2 | — | — | — | — | 2 |
Mycosis fungoides | D009182 | — | C84.0 | 2 | — | — | — | — | 2 |
T-cell lymphoma cutaneous | D016410 | — | C84.A | 2 | — | — | — | — | 2 |
Bone fractures | D050723 | EFO_0003931 | T14.8 | 1 | — | — | — | 1 | 2 |
Multiple sclerosis | D009103 | EFO_0003885 | G35 | 1 | — | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Folic acid deficiency | D005494 | EFO_0001070 | E53.8 | — | — | — | — | 12 | 12 |
Deglutition disorders | D003680 | — | R13.1 | — | — | — | — | 8 | 8 |
Gyrate atrophy | D015799 | — | — | — | — | — | — | 6 | 6 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | — | — | 6 | 6 |
Vitamin a deficiency | D014802 | EFO_1001237 | E50 | — | — | — | — | 6 | 6 |
Gastroesophageal reflux | D005764 | EFO_0003948 | K21 | — | — | — | — | 6 | 6 |
Wounds and injuries | D014947 | — | T14.8 | — | — | — | — | 4 | 4 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 4 | 4 |
Fatigue | D005221 | — | R53.83 | — | — | — | — | 4 | 4 |
Body weight | D001835 | EFO_0004338 | — | — | — | — | — | 4 | 4 |
Drug common name | Cyanocobalamin |
INN | cyanocobalamin |
Description | Cyanocobalamin is a form of vitamin B12 used to treat vitamin B12 deficiency except in the presence of cyanide toxicity. The deficiency may occur in pernicious anemia, following surgical removal of the stomach, with fish tapeworm, or due to bowel cancer. It is less preferred than hydroxocobalamin for treating vitamin B12 deficiency. Some study have shown that it has an antihypotensive effect. It is used by mouth, by injection into a muscle, or as a nasal spray.
|
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | 68-19-9 |
RxCUI | — |
ChEMBL ID | CHEMBL2110563 |
ChEBI ID | — |
PubChem CID | 16212801 |
DrugBank | DB00115 |
UNII ID | P6YC3EG204 (ChemIDplus, GSRS) |